These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 910468)

  • 21. Visken (LB-46) a double blind cross-over study in cardiac arrhythmias.
    Damany SJ; Bhatt GR
    Indian Heart J; 1972 Jun; 24():Suppl 1:211-2. PubMed ID: 4581429
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 24. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
    Török E; Jávor T; Szám I; Gábor G
    Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)].
    Werning C
    Med Klin; 1973 Nov; 68(47):1559-63. PubMed ID: 4781097
    [No Abstract]   [Full Text] [Related]  

  • 26. A double blind drug trial of LB-46 (visken) in angina pectoris.
    Sainani GS; Mukherjee AK
    Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes.
    Sonkodi S; Pap A; Varró V
    Ther Hung; 1976; 24(2):60-2. PubMed ID: 982340
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intravenous acebutolol in supraventricular arrhythmias and ventricular extrasystole. Experience in 22 cases].
    Yenes A; Chamorro H; González G
    Rev Med Chil; 1984 Jan; 112(1):32-5. PubMed ID: 6204365
    [No Abstract]   [Full Text] [Related]  

  • 30. [Systolic times of the left ventricle in hypertrophic obstructive cardiomyopathy: effects of beta-adrenergic stimulation and blocking].
    Giovannini E; Ferrari O; Pace F; Milazzotto F
    Boll Soc Ital Cardiol; 1975; 20(11):1595-600. PubMed ID: 1241953
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of visken on the circulation and respiration in the postoperative period.
    Pulay I; Weltner J; Darvas K; Alánt O
    Ther Hung; 1979; 27(4):185-8. PubMed ID: 538750
    [No Abstract]   [Full Text] [Related]  

  • 32. [Visken. Study of its action on atrial rhythm disorders and on chronic insufficiency. Apropos of 50 cases].
    Waucampt JJ; Decalf A; Delmon A; Goethals S; Pauchant M
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1297-302. PubMed ID: 4802883
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension].
    Savenkov PM; Doshitsin VL; Grudtsyn GV
    Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Various types of beta-receptor blockers in clinical anesthesia. 3. Pindolol (LB-46)].
    Miyazaki M; Fujita T
    Masui; 1971 Jul; 20(7):589-97. PubMed ID: 4397813
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of pindolol on the automatism of the sinus node and on atrioventricular and intraventricular conduction in man].
    Santini M; Dini P; Di Mascolo R; Milazzotto F; Jacovella G
    Minerva Cardioangiol; 1975 Nov; 23(11):760-5. PubMed ID: 1223679
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of pindolol in the treatment of arrhythmia with beta-blocking agents].
    Witchitz S; Benaim R; Haiat R; Chapelle M; Chiche P
    Ann Cardiol Angeiol (Paris); 1972; 21(3):297-301. PubMed ID: 4649326
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of long-term administration of Pindolol (LB-46, Visken) in essential circulatory hyperkinesis. A double-blind, cross-over study.
    Békés M; Polák G; Istvánffy M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1974 Mar; 9(2):87-92. PubMed ID: 4208032
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of beta blockaders in arrhythmias and ischemic heart disease].
    Rosselot E
    Rev Med Chil; 1982 Dec; 110(12):1224-32. PubMed ID: 6135249
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pindolol eye drops (Glauco-Visken) - half year's results in glaucoma therapy].
    Merté HJ; Stryz JR; Mertz M
    Klin Monbl Augenheilkd; 1984 Mar; 184(3):227-32. PubMed ID: 6374263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arrhythmias and antiarrhythmic drugs.
    Bigger JT
    Adv Intern Med; 1972; 18():251-81. PubMed ID: 4576083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.